This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Kribben, A. Articles by Erbel, R. Search for Related Content PubMed PubMed Citation Articles by Kribben, A. Articles by Erbel, R. Related Collections Related Article

STATE-OF-THE-ART PAPER

Nephrogenic Systemic Fibrosis

Pathogenesis, Diagnosis, and Therapy

Andreas Kribben, MD^_*,_*, Oliver Witzke, MD^_*, Uwe Hillen, MD, Jörg Barkhausen, MD, Anton E. Daul, MD^|| and Raimund Erbel, MD

^_* Department of Nephrology, University Duisburg-Essen, Essen, Germany
Department of Dermatology, University Duisburg-Essen, Essen, Germany
Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Duisburg-Essen, Essen, Germany
Department of Cardiology, University Duisburg-Essen, Essen, Germany
^|| Department of Internal Medicine, Division of Nephrology, Elisabeth Hospital Essen, Essen, Germany

Manuscript received August 11, 2008; revised manuscript received December 3, 2008, accepted December 8, 2008.

^_* Reprint requests and correspondence: Dr. Andreas Kribben, Department of Nephrology, University Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany (Email: andreas.kribben{at}uni-due.de).

Nephrogenic systemic fibrosis (NSF) is a newly recognized disorder occurring exclusively in patients with renal failure. Exposure to gadolinium-based magnetic resonance (MR) contrast media has been associated with subsequent development of NSF. Nephrogenic systemic fibrosis is characterized by skin induration preferentially affecting the extremities. In addition, involvement of internal organs occurs, which leads ultimately to death. Skin biopsy is important for confirmation of the diagnosis. The main therapeutic goal is restoration of renal function. To reduce the risk of NSF, renal function must be determined before exposure to gadolinium-containing MR contrast agents. Gadolinium-based MR contrast media should be avoided in the presence of advanced renal failure with estimated glomerular filtration rate below 30 ml/min/1.73 m², unless the diagnostic information is essential and not available with noncontrast magnetic resonance imaging techniques. The recommended dose of contrast agent should not be exceeded. In addition, a sufficient period of time for elimination of the contrast agent from the body should be allowed before readministration of the contrast agent.

Key Words: gadolinium • magnetic resonance imaging • nephrogenic systemic fibrosis • renal failure

Abbreviations and Acronyms   AKI = acute kidney injury   CKD = chronic kidney disease   FDA = Food and Drug Administration   GFR = glomerular filtration rate   MRA = magnetic resonance angiography   MRI = magnetic resonance imaging   NSF = nephrogenic systemic fibrosis

Related Article

Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A24. [Full Text] [PDF]

This article has been cited by other articles:

				D. W. den Uijl, V. Delgado, M. Bertini, L. F. Tops, S. A. Trines, N. R. van de Veire, K. Zeppenfeld, M. J. Schalij, and J. J. Bax Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation Heart, November 15, 2011; 97(22): 1847 - 1851. [Abstract] [Full Text] [PDF]

				Endorsed by: the European Stroke Organisation (ESO, Authors/Task Force Members, M. Tendera, V. Aboyans, M.-L. Bartelink, I. Baumgartner, D. Clement, J.-P. Collet, A. Cremonesi, M. De Carlo, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC) Eur. Heart J., November 2, 2011; 32(22): 2851 - 2906. [Full Text] [PDF]

				K. R. Kalisz, A. H. Davarpanah, A. A. Usman, J. D. Collins, T. J. Carroll, and J. C. Carr Detection of Renal Dysfunction by Point-of-Care Creatinine Testing in Patients Undergoing Peripheral MR Angiography Am. J. Roentgenol., August 1, 2011; 197(2): 430 - 435. [Abstract] [Full Text] [PDF]

				M. Perazzolo Marra, J. A. C. Lima, and S. Iliceto MRI in acute myocardial infarction Eur. Heart J., February 1, 2011; 32(3): 284 - 293. [Abstract] [Full Text] [PDF]

				G. A. Figtree, J. Lonborg, S. M. Grieve, M. R. Ward, and R. Bhindi Cardiac Magnetic Resonance Imaging for the Interventional Cardiologist J. Am. Coll. Cardiol. Intv., February 1, 2011; 4(2): 137 - 148. [Abstract] [Full Text] [PDF]

				R. Blankstein and A. D. DeVore Selecting a Noninvasive Imaging Study After an Inconclusive Exercise Test Circulation, October 12, 2010; 122(15): 1514 - 1518. [Full Text] [PDF]

				N. Lameire, J. Floege, and D. C. Wheeler The five most cited NDT papers from 2005 to 2009 Nephrol. Dial. Transplant., September 1, 2010; 25(9): 2825 - 2831. [Full Text] [PDF]

				K. Abdel-Kader, P. R. Patel, A. J. Kallen, R. L. Sinkowitz-Cochran, W. K. Bolton, and M. L. Unruh Nephrogenic Systemic Fibrosis: A Survey of Nephrologists' Perceptions and Practices Clin. J. Am. Soc. Nephrol., June 1, 2010; 5(6): 964 - 971. [Abstract] [Full Text] [PDF]

				P. Stratta, C. Canavese, M. Quaglia, and R. Fenoglio Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network Rheumatology, April 1, 2010; 49(4): 821 - 823. [Full Text] [PDF]

				A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al. Highlights of the Year in JACC 2009 J. Am. Coll. Cardiol., January 26, 2010; 55(4): 380 - 407. [Full Text] [PDF]

				H. W. Kim, A. Farzaneh-Far, and R. J. Kim Cardiovascular Magnetic Resonance in Patients With Myocardial Infarction: Current and Emerging Applications J. Am. Coll. Cardiol., January 5, 2010; 55(1): 1 - 16. [Abstract] [Full Text] [PDF]

				R. J. Glassock, R. Pecoits-Filho, and S. H. Barberato Left Ventricular Mass in Chronic Kidney Disease and ESRD Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S79 - S91. [Abstract] [Full Text] [PDF]

				M. R. Prince, H. L. Zhang, J. C. Prowda, M. E. Grossman, and D. N. Silvers Nephrogenic Systemic Fibrosis and Its Impact on Abdominal Imaging RadioGraphics, October 1, 2009; 29(6): 1565 - 1574. [Abstract] [Full Text] [PDF]